English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23351266      線上人數 : 440
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32570


    標題: Evaluation of Clinical Outcome and Risk Factors for Failure of Single-incision Midurethral Short Tape Procedure (Solyx Tape) for Stress Urinary Incontinence
    作者: Lo, Tsia-Shu
    Shailaja, Nagashu
    Chua, Sandy
    Tseng, Ling-Hong
    Kao, Chuan-Chi
    Ming-Ping Wu(吳銘斌)
    貢獻者: Chang Gung Mem Hosp, Keelung Med Ctr, Dept Obstet & Gynecol
    Chang Gung Mem Hosp, Dept Obstet & Gynecol, Div Urogynecol, Linkou Med Ctr
    Chang Gung Univ, Sch Med
    Peoples Eibrat Soc Med Coll & Res Ctr, Dept Obstet & Gynaecol
    Cebu Velez Gen Hosp, Dept Obstet & Gynecol
    Chi Mei Fdn Hosp, Dept Obstet & Gynecol, Div Urogynecol & Pelv Floor Reconstruct
    Chia Nan Univ Pharm & Sci, Ctr Gen Educ
    關鍵字: Efficacy
    Outcomes
    Risk factors
    Safety
    Solyx
    Stress incontinence
    日期: 2019-05
    上傳時間: 2020-07-29 13:50:19 (UTC+8)
    出版者: ELSEVIER SCIENCE INC
    摘要: Study Objective: To evaluate the clinical outcome and identify risk factors for failure of the Solyx (Boston Scientific Corporation, Marlborough, MA) single-incision sling (SIS) in the treatment of urodynamic stress incontinence (USI). Design: A retrospective observational study (Canadian Task Force classification II-2). Setting: A tertiary referral center. Patients: Patients diagnosed with USI without needing concurrent procedures that underwent continence surgery using the Solyx SIS from February 2015 to May 2017. Interventions: Anti-incontinence surgery. Measurements and Main Results: The primary outcome of this study was the rate of objective cure defined as the absence of demonstrable leakage of urine on the cough stress test and a 1-hour pad test weight of less than 2 g. The secondary outcome was the rate of subjective cure defined as a negative response to Urinary Distress Inventory question 3 (no leakage on coughing, sneezing, or laughing) and the identification of the different risk factors of cure failure. A total of 113 patients were evaluated in the study. Postoperative USI and the 1-hour pad test significantly improved from 24.2 +/- 26.9 gm (range, 19.1-29.3) to 2.5 +/- 8.7 gm (range, 0.9-4.2); p < 0.001 through 1 year. Data analysis showed an objective cure rate of 90% (102/113) and a subjective cure rate of 86% (97/113). USI recurred in 11 patients with no repeat surgery done because symptoms were tolerable to the patients. No patient had bladder outlet obstruction. Peak flow rates 23.7 +/- 9.1 ml/s (20.0-27.4) and residual urine volume 38.5 +/- 25.8 ml (29.8-47.2) were within normal limits with no significant changes. Previous anti-incontinent surgery, previous prolapsed surgery, intrinsic sphincter deficiency, maximum urethral closure pressure < 40 cm H2O, and neurogenic disease were significant risk factors for sling failure. Subjective assessment on the quality of life significantly improved (p < 0.001). Conclusion: The Solyx SIS is an effective and safe treatment option for women with USI, showing high objective and subjective cure rates with a low incidence of complications 1 year after treatment. The identified independent risk factors for failure are related to poor urethral function and previous pelvic reconstructive surgery. (C) 2018 AAGL. All rights reserved.
    關聯: Journal of Minimally Invasive Gynecology, v.26, n.4, pp.688-694
    顯示於類別:[通識教育中心] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML789檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋